Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

These hair loss conditions might be part of a spectrum, not separate issues.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mouse skin fibroblasts vary in function and adaptability based on their environment.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Differentiated fibroblasts regenerate hair follicles better than undifferentiated ones.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

The treatment combining laser and fetal fibroblasts effectively reduces scarring.

Myofibroblasts in rat wound healing may come from blood vessel pericytes and perifollicular dermal sheath cells.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The skin can still regenerate and function well even with fewer fibroblasts.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.